Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.

Breukers SE, Traets JJH, van Dijk SW, Ostos MM, Fraterman I, Crommelin RD, van der Hulst H, Qiao X, Boere T, van de Poll-Franse LV, Retèl V, van der Noort V, Vos JL, Toppenberg AGL, van der Heijden M, Missale F, Balm F, van den Brekel M, Dirven R, Karakullukcu MB, Karssemakers L, Klop WMC, Lohuis PJFM, Schreuder WH, Smeele LE, van der Velden LA, Plasmeijer E, Smit LA, de Boer JP, Navran A, Westerink B, de Koekkoek-Doll PK, Castelijns J, Wondergem M, Vogel WV, Kuijpers A, van Houdt WJ, Onderwater S, Maas-Bannink E, Cornelissen S, Broeks A, Tijink BM, Devriese LA, de Bree R, Blank CU, Schumacher TN, Thommen DS, Haanen JBAG, Zuur CL

Open source

DOI
10.1038/s41591-025-03943-w
Published
2025 Dec
Container
Nature medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-025-03943-w,
  title = {Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.},
  author = {Breukers SE and Traets JJH and van Dijk SW and Ostos MM and Fraterman I and Crommelin RD and van der Hulst H and Qiao X and Boere T and van de Poll-Franse LV and Retèl V and van der Noort V and Vos JL and Toppenberg AGL and van der Heijden M and Missale F and Balm F and van den Brekel M and Dirven R and Karakullukcu MB and Karssemakers L and Klop WMC and Lohuis PJFM and Schreuder WH and Smeele LE and van der Velden LA and Plasmeijer E and Smit LA and de Boer JP and Navran A and Westerink B and de Koekkoek-Doll PK and Castelijns J and Wondergem M and Vogel WV and Kuijpers A and van Houdt WJ and Onderwater S and Maas-Bannink E and Cornelissen S and Broeks A and Tijink BM and Devriese LA and de Bree R and Blank CU and Schumacher TN and Thommen DS and Haanen JBAG and Zuur CL},
  year = {2025},
  journal = {Nature medicine},
  doi = {10.1038/s41591-025-03943-w},
  url = {https://doi.org/10.1038/s41591-025-03943-w}
}

RIS

TY  - JOUR
TI  - Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.
AU  - Breukers SE
AU  - Traets JJH
AU  - van Dijk SW
AU  - Ostos MM
AU  - Fraterman I
AU  - Crommelin RD
AU  - van der Hulst H
AU  - Qiao X
AU  - Boere T
AU  - van de Poll-Franse LV
AU  - Retèl V
AU  - van der Noort V
AU  - Vos JL
AU  - Toppenberg AGL
AU  - van der Heijden M
AU  - Missale F
AU  - Balm F
AU  - van den Brekel M
AU  - Dirven R
AU  - Karakullukcu MB
AU  - Karssemakers L
AU  - Klop WMC
AU  - Lohuis PJFM
AU  - Schreuder WH
AU  - Smeele LE
AU  - van der Velden LA
AU  - Plasmeijer E
AU  - Smit LA
AU  - de Boer JP
AU  - Navran A
AU  - Westerink B
AU  - de Koekkoek-Doll PK
AU  - Castelijns J
AU  - Wondergem M
AU  - Vogel WV
AU  - Kuijpers A
AU  - van Houdt WJ
AU  - Onderwater S
AU  - Maas-Bannink E
AU  - Cornelissen S
AU  - Broeks A
AU  - Tijink BM
AU  - Devriese LA
AU  - de Bree R
AU  - Blank CU
AU  - Schumacher TN
AU  - Thommen DS
AU  - Haanen JBAG
AU  - Zuur CL
PY  - 2025
JO  - Nature medicine
DO  - 10.1038/s41591-025-03943-w
UR  - https://doi.org/10.1038/s41591-025-03943-w
ER  -

APA

SE, B., JJH, T., SW, V. D., MM, O., I, F., RD, C., H, V. D. H., X, Q., T, B., LV, V. D. P., V, R., V, V. D. N., JL, V., AGL, T., M, V. D. H., F, M., F, B., M, V. D. B., R, D., MB, K., L, K., WMC, K., PJFM, L., WH, S., LE, S., LA, V. D. V., E, P., LA, S., JP, D. B., A, N., B, W., PK, D. K., J, C., M, W., WV, V., A, K., WJ, V. H., S, O., E, M., S, C., A, B., BM, T., LA, D., R, D. B., CU, B., TN, S., DS, T., JBAG, H., & CL, Z. (2025). Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.. Nature medicine. https://doi.org/10.1038/s41591-025-03943-w

Source records